Adenike Amadi

Adenike Amadi is an author at Bristol-Myers Squibb (United Kingdom) specializing in immunotherapy, checkpoint inhibitor therapy, and immunotherapy for skin cancer.

Publications per year

2020–2022

3

Publications

3